Spots Global Cancer Trial Database for plasma cell neoplasm
Every month we try and update this database with for plasma cell neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma | NCT05336383 | Multiple Myelom... Plasma Cell Neo... Malignant Plasm... | Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma | NCT04309084 | Multiple Myelom... Neoplasm, Plasm... Neoplasms by Hi... Neoplasms Hemostatic Diso... Vascular Diseas... Cardiovascular ... Paraproteinemia... Blood Protein D... Hematologic Dis... Hemorrhagic Dis... Lymphoprolifera... Immunoprolifera... Immune System D... Antineoplastic ... Analgesics, Non... Analgesics Sensory System ... Peripheral Nerv... Physiological E... | CYNK-001 | 18 Years - 75 Years | Celularity Incorporated | |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | NCT00303719 | Kidney Cancer Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | anti-thymocyte ... cyclophosphamid... cyclosporine fludarabine mycophenolate m... stem cell trans... total body irra... filgrastim | - 75 Years | Masonic Cancer Center, University of Minnesota | |
| S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma | NCT00064038 | Multiple Myelom... Plasma Cell Neo... | dexamethasone lenalidomide placebo | 18 Years - | SWOG Cancer Research Network | |
| Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT00729118 | Multiple Myelom... Plasma Cell Neo... | lenalidomide vorinostat | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis | NCT00075608 | Multiple Myelom... Plasma Cell Neo... | filgrastim melphalan autologous stem... stem cell infus... | 18 Years - 65 Years | Boston Medical Center | |
| Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance | NCT01647165 | Multiple Myelom... | Bortezomib Lenalidomide Dexamethasone | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
| CI-994 in Treating Patients With Advanced Myeloma | NCT00005624 | Multiple Myelom... | CI-994 | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | NCT00012350 | Multiple Myelom... | FTI | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma | NCT00400686 | Anemia Multiple Myelom... Plasma Cell Neo... | epoetin alfa | 18 Years - | The Cleveland Clinic | |
| Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | NCT00012350 | Multiple Myelom... | FTI | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma | NCT00064038 | Multiple Myelom... Plasma Cell Neo... | dexamethasone lenalidomide placebo | 18 Years - | SWOG Cancer Research Network | |
| A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma | NCT01219010 | Monoclonal Gamm... Multiple Myelom... Plasma Cell Neo... | Siltuximab | 18 Years - | Janssen Research & Development, LLC | |
| Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction | NCT00547365 | Multiple Myelom... Plasma Cell Neo... | Human immune gl... | 18 Years - | University of Tennessee | |
| S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma | NCT00064038 | Multiple Myelom... Plasma Cell Neo... | dexamethasone lenalidomide placebo | 18 Years - | SWOG Cancer Research Network | |
| A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies | NCT03999697 | Diffuse Large B... Follicular Lymp... Primary Cutaneo... Extranodal Marg... Mantle Cell Lym... Plasma Cell Neo... B Cell Lymphoma | Autologous chim... | 3 Years - 70 Years | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | NCT00602693 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | umbilical cord ... Allopurinol fludarabine pho... Cyclophosphamid... Total body irra... Treg infusion Sirolimus | 18 Years - 75 Years | Masonic Cancer Center, University of Minnesota | |
| Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT00028600 | Multiple Myelom... Plasma Cell Neo... | filgrastim CD34+ cells cyclophosphamid... fludarabine pho... melphalan methotrexate tacrolimus | - 64 Years | Alliance for Clinical Trials in Oncology | |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | NCT00303719 | Kidney Cancer Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | anti-thymocyte ... cyclophosphamid... cyclosporine fludarabine mycophenolate m... stem cell trans... total body irra... filgrastim | - 75 Years | Masonic Cancer Center, University of Minnesota | |
| Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma | NCT00400686 | Anemia Multiple Myelom... Plasma Cell Neo... | epoetin alfa | 18 Years - | The Cleveland Clinic | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | NCT00005792 | Multiple Myelom... Plasma Cell Neo... | etoposide phosp... melphalan topotecan Autologous Stem... | 15 Years - 69 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction | NCT00790842 | Multiple Myelom... Plasma Cell Neo... | Lenalidomide Dexamethasone Anticoagulants | 18 Years - | PrECOG, LLC. | |
| Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma | NCT00118339 | Multiple Myelom... Plasma Cell Neo... | chemoprotection complementary o... management of t... | 18 Years - | Fred Hutchinson Cancer Center | |
| Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | NCT00012350 | Multiple Myelom... | FTI | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders | NCT04080531 | Plasma Cell Neo... | Pneumococcal 13... Trivalent Influ... | 18 Years - | Emory University | |
| Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction | NCT00790842 | Multiple Myelom... Plasma Cell Neo... | Lenalidomide Dexamethasone Anticoagulants | 18 Years - | PrECOG, LLC. | |
| Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy | NCT01132833 | Multiple Myelom... Plasma Cell Neo... Thromboembolism | enzyme-linked i... laboratory biom... medical chart r... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma | NCT00118339 | Multiple Myelom... Plasma Cell Neo... | chemoprotection complementary o... management of t... | 18 Years - | Fred Hutchinson Cancer Center | |
| Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies | NCT02556931 | Myelodysplastic... Chronic Myelomo... Small Lymphocyt... Chronic Lymphoc... Prolymphocytic ... Chronic Myeloid... Chronic Myelopr... Multiple Myelom... Plasma Cell Neo... Plasma Cell Dys... Myelofibrosis Polycythemia Ve... Essential Throm... Plasma Cell Leu... | Fludarabine Cyclophosphamid... Total body irra... Tacrolimus Mycophenolate m... | - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
| 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis | NCT00075608 | Multiple Myelom... Plasma Cell Neo... | filgrastim melphalan autologous stem... stem cell infus... | 18 Years - 65 Years | Boston Medical Center | |
| Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) | NCT01109407 | Smoldering Myel... Monoclonal Gamm... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases | NCT00874211 | Breast Cancer Lung Cancer Metastatic Canc... Multiple Myelom... Plasma Cell Neo... Prostate Cancer Unspecified Adu... | assessment of t... | - 120 Years | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
